EN PL

EMA: Scientific guideline: Questions & Answers: positions on specific questions addressed to the EWP therapeutic subgroup on pharmacokinetics

04.08.2010
In the context of assessment procedures, the Therapeutic Subgroup on Pharmacokinetics of the Efficacy Working Party (EWP-PK subgroup) is occasionally consulted by the CHMP or, following CHMP’s agreement, by other Committees, Working parties or the CMD(h). The objective is to address specific questions in relation to pharmacokinetic evaluations and particularly the requirements and assessment of bioequivalence studies.